Hopewell Junction, NY, United States of America

Wenjie Li

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Pittsburgh, PA (US) (2001)
  • Edison, NJ (US) (2007 - 2008)
  • Hopewell Junction, NY (US) (2008 - 2015)

Company Filing History:


Years Active: 2001-2015

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: The Innovative Contributions of Wenjie Li

Introduction

Wenjie Li is a notable inventor based in Hopewell Junction, NY (US), recognized for his significant contributions to the field of pharmaceutical chemistry. With a total of seven patents to his name, he has made strides in developing processes and compounds that have the potential to address various health issues.

Latest Patents

Among his latest patents is a process for asymmetric methylallylation in the presence of a 2,2'-substituted 1,1'-BI-2-naphthol catalyst. This invention discloses a process and catalysts that are useful for carrying out asymmetric methylallylations. The catalysts utilized in this invention have a specific formula, and the compounds produced can be employed to prepare pharmaceutically active compounds, including 11-β-hydroxysteroid hydrogenase type 1 (11-β-HSD1) inhibitors. Another significant patent involves the synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1. This patent outlines syntheses of 11β-HSD1 inhibitors and their corresponding intermediates, which show promise for treating various disease states such as diabetes, metabolic syndrome, obesity, and more.

Career Highlights

Wenjie Li has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in developing innovative solutions in drug synthesis and design.

Collaborations

Throughout his career, Wenjie Li has collaborated with several professionals in the field, including Lushi Tan and Robert D. Larsen. These collaborations have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Wenjie Li's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving health outcomes. His contributions are invaluable to the ongoing efforts in drug development and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…